This study bodes to show medical cannabis has the potential to improve and dignify the way people with terminal illnesses who are in dire pain spend the last stages of their lives – both with reduced pain – and fully awake, able to socialize. Which is very different from how these processes generally play out today in most cases.
This has other implications. Reshaping the terminal health care system could also effect the way palliative medicine is approached across many aspects of the medical care field.
Highest TRUCE recommendation.
Also worth noting here is that Dr. Nora Volkow at the National Institute on Drug Abuse is ever so gradually starting to sing a different song, sounding here almost like a semi-advocate (if here only in the sole case of chronic, intractable pain). But even so, this is an improvement in the agency’s history of not getting behind any studies looking at benefits after many years of funding looking for harms nearly exclusively.
“Nora Volkow, director of NIDA coauthored an article in July that said there is ‘strong evidence of the efficacy of cannabinoids’ in pain treatment. The article said that medical cannabis could ‘provide a powerful new tool’ in the fight against opiates.”
In the world of mixed good news, this being NIDA – with its ties to the other alphabet agencies in the drug enforcement and approval businesses – the product being tested is a proprietary high CBD/low THC capsule, almost certainly the product of a major pharma company.
Still, we’ll welcome the study, as we believe it’s been established that anything positive this medication can do, preparations of whole plant medicine will be able to do at least as well or better.
#MMJ #Research #Hospice #Palliative #UTpol #TRUCE
See full article – This Hospice Is Hoping To Prove That Cannabis Can Make Dying Less Painful